GL1X · GenesisL1 explorer

MolNFT v1 · #179852 · protein

Crystal structure of oxa-163 K73A in complex with meropenem

7KHY · Beta-lactamase: “Crystal structure of oxa-163 K73A in complex with meropenem”. X-ray diffraction, 3 ligands (MER, ZN, CL), 3 pockets (best druggability 0.37). MolNFT v1 #179852 on GenesisL1: 3D structure, binding sites and pockets…

PDB
7KHY
Type
protein
Length
237 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
F6KZJ2
Ligands
MER, ZN, CL
Pockets
3 · best druggability 0.37

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein23741% helix, 21% strandF6KZJ2

Ligands and binding sites

  • MER · (4R,5S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid · ligand · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A
  • CL · Chloride ion · ion · 2 copies · chains A
  • MPD · (4S)-2-methyl-2,4-pentanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1570.370.7919empty
2660.280.7317MER
3520.270.7413empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7KHY · Crystal structure of OXA-163 K73A in complex with meropenem · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.